Research ArticleHEAD & NECK
Do We Need Gadolinium-Based Contrast Agents for Routine MRI Surveillance of Unoperated Pituitary Macroadenoma?
A.A. Alali, P.B. Hanagandi and P.J. Maralani
American Journal of Neuroradiology June 2022, DOI: https://doi.org/10.3174/ajnr.A7554
A.A. Alali
aFrom the Division of Neuroradiology (A.A.A.), King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia
P.B. Hanagandi
bDepartment of Medical Imaging (P.B.H.), King Abdulaziz Medical City NGHA, Riyadh, Saudi Arabia
P.J. Maralani
cDivision of Neuroradiology (P.J.M.), Department of Medical Imaging, University of Toronto, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada

Jump to comment:
No eLetters have been published for this article.
Advertisement
A.A. Alali, P.B. Hanagandi, P.J. Maralani
Do We Need Gadolinium-Based Contrast Agents for Routine MRI Surveillance of Unoperated Pituitary Macroadenoma?
American Journal of Neuroradiology Jun 2022, DOI: 10.3174/ajnr.A7554
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.
This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.
More in this TOC Section
Similar Articles
Advertisement